Chemical synthesis and proinflammatory responses of monophosphoryl lipid A adjuvant candidates (Q33714195)

28 July 2017

Chemical synthesis and proinflammatory responses of monophosphoryl lipid A adjuvant candidates (English)

1 reference

28 July 2017

Margreet A Wolfert

5

0 references

Geert-Jan Boons

object named as

Geert-Jan Boons

6

0 references

author name string

Kaustabh K Maiti

1

1 reference

28 July 2017

Michael Decastro

2

1 reference

28 July 2017

Abu-Baker M Abdel-Aal El-Sayed

3

1 reference

28 July 2017

Matthew I Foote

4

1 reference

28 July 2017

1 January 2010

1 reference

European Journal of Organic Chemistry

28 July 2017

1 reference

28 July 2017

2010

1 reference

28 July 2017

1

1 reference

28 July 2017

80-91

1 reference

Vaccine adjuvants: scientific challenges and strategic initiatives

28 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835315

Increasing the antigenicity of synthetic tumor-associated carbohydrate antigens by targeting Toll-like receptors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835315

New horizons in adjuvants for vaccine development

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835315

Engagement of TLR signaling as adjuvant: towards smarter vaccine and beyond

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835315

Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835315

Synthetic TLR4-active glycolipids as vaccine adjuvants and stand-alone immunotherapeutics

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835315

Sensing gram-negative bacterial lipopolysaccharides: a human disease determinant?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835315

How do adjuvants work? Important considerations for new generation adjuvants

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835315

Innate immune responses of synthetic lipid A derivatives of Neisseria meningitidis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835315

E6020: a synthetic Toll-like receptor 4 agonist as a vaccine adjuvant

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835315

21 June 2018

The science of adjuvants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835315

Adjuvants in vaccines and for immunisation: current trends

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835315

Robust immune responses elicited by a fully synthetic three-component vaccine

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835315

The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835315

Modulation of innate immune responses with synthetic lipid A derivatives

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835315

Vaccine adjuvants revisited

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835315

A potent adjuvant monophosphoryl lipid A triggers various immune responses, but not secretion of IL-1beta or activation of caspase-1.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835315

Synthesis of lipid A and its analogues for investigation of the structural basis for their bioactivity

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835315

Helping the CD8(+) T-cell response

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835315

Can innate immunity be enhanced to treat microbial infections?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835315

Toll-like receptors and acquired immunity

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835315

Innate immunity: an overview

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835315

Enhancement of antigen-specific immunity via the TLR4 ligands MPL adjuvant and Ribi.529.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835315

Synthetic vaccines: the role of adjuvants in immune targeting

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835315

Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835315

Toll-like receptors and T-helper-1/T-helper-2 responses

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835315

Structural and functional analyses of bacterial lipopolysaccharides.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835315

Lipopolysaccharide endotoxins

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835315

Recent developments in adjuvants for vaccines against infectious diseases

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835315

Toll-like receptors: critical proteins linking innate and acquired immunity

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835315

3-O-Desacyl monophosphoryl lipid A derivatives: synthesis and immunostimulant activities

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835315

Lipid A diversity and the innate host response to bacterial infection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835315

Lipopolysaccharide and monophosphoryl lipid A differentially regulate interleukin-12, gamma interferon, and interleukin-10 mRNA production in murine macrophages.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835315

Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2835315

Lipid A and liposomes containing lipid A as antigens and adjuvants

21 June 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJOC.200900973

Toll-dependent control mechanisms of CD4 T cell activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJOC.200900973

Towards a Fully Synthetic Carbohydrate-Based Anticancer Vaccine: Synthesis and Immunological Evaluation of a Lipidated Glycopeptide Containing the Tumor-Associated Tn Antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJOC.200900973

Monophosphoryl lipid A analogues with varying 3-O-substitution: synthesis and potent adjuvant activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJOC.200900973

N-trichloroethoxycarbonyl-glucosamine derivatives as glycosyl donors

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20228877

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Anomeric-oxygen activation for glycoside synthesis: the trichloroacetimidate method

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20228877

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/EJOC.200900973

1 reference

28 July 2017

1 reference

28 July 2017

1 reference